Post-Traumatic Stress Disorder (PTSD) is an intense anxiety response triggered by experiencing or witnessing a life-threatening event. 

This condition often leads individuals to avoid places or situations that remind them of the trauma, significantly impacting their quality of life and hindering their ability to function normally in daily activities for an extended period.

Approximately 8% of the general population will experience PTSD in their lifetime, with an additional 5-15% potentially experiencing sub-clinical forms. 

Women are more likely to develop PTSD than men, and it's also more prevalent among young adults due to their higher likelihood of encountering traumatic events. 

PTSD can also affect children and adolescents. Historically, the types of traumatic events leading to PTSD have differed between genders; men often develop it after combat exposure, while women more commonly experience it following physical or sexual assault.

Today, many PTSD cases in the general population stem from exposure to traffic accidents or work-related incidents. 

The disorder is particularly common among war veterans; for example, 30% of Vietnam War veterans developed PTSD, with another 25% experiencing a sub-clinical form.

While often associated with military combat, PTSD isn't exclusive to veterans. 

For instance, many female rape victims no longer meet the diagnostic criteria for PTSD just three months after the assault.

Several factors influence a person's likelihood of developing PTSD, including the support they receive after the traumatic event, the environment's attitude toward the event, the provision of immediate care (as a lack thereof can perpetuate the condition), and individual predispositions. 

Traditional treatments for PTSD aim to alleviate symptoms, but their effectiveness can vary. 

Antidepressant medications can help ease depressive and anxiety symptoms but often don't provide relief for other debilitating symptoms that impair daily functioning. 

Cognitive-behavioral therapies (CBT), which may involve exposure to traumatic memories, and other psychotherapeutic methods have shown some success, though often only partial and in a limited number of patients. 

Functional magnetic resonance imaging (fMRI) studies have demonstrated that extreme traumatic events can cause significant alterations in neural activity patterns across various brain regions.

Sunny Skies Healthcare ™  offers an innovative, non-invasive, and generally safe treatment for PTSD using Deep Transcranial Magnetic Stimulation (Deep TMS™).

This therapy involves magnetic stimulation of specific brain structures and networks implicated in PTSD, leading to significant improvement for many patients.

This treatment presents several advantages over other options. 

It's an outpatient procedure, meaning no hospitalization or anesthesia is required. 

It's typically well-tolerated and associated with minimal systemic side effects.

You are viewing a page that is not intended for persons in the United States, and includes information about treatment applications that HAVE NOT BEEN CLEARED by the FDA for safety and efficacy.

However, BrainsWay Deep TMS™ has received the European CE Mark for the treatment of many conditions.

This significant approval underscores the therapy's established safety and efficacy for these indications in Europe. While regulatory statuses vary by region, this CE Mark highlights the recognized potential of Deep TMS as a therapeutic option for:

Major Depressive Disorder (MDD)

Anxiety Depression

Obsessive-Compulsive Disorder (OCD)

Smoking Cessation

Alzheimer's Disease (AD)

Autism

Bipolar Disorder

Chronic Pain

Multiple Sclerosis (MS)

Parkinson's Disease

Post-Stroke Rehabilitation

Post-Traumatic Stress Disorder (PTSD)

Negative Symptoms of Schizophrenia